Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants
Open Access
- 30 October 2009
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 39 (11), 3000-3009
- https://doi.org/10.1002/eji.200838980
Abstract
The contribution of direct and indirect alloresponses by CD4+ Th1 and Th2 cells in acute and chronic rejection of allogeneic transplants remains unclear. In the present study, we addressed this question using a transplant model in a single MHC class I‐disparate donor–recipient mouse combination. BALB/c‐dm2 (dm2) mutant mice do not express MHC class I Ld molecules and reject acutely Ld+ skin grafts from BALB/c mice. In contrast, BALB/c hearts placed in dm2 mice are permanently accepted in the absence of chronic allograft vasculopathy. In this model, CD4+ T cells are activated following recognition of a donor MHC class I determinant, Ld 61–80, presented by MHC Class II Ad molecules on donor and recipient APC. Pre‐transplantation of recipients with Ld 61–80 peptide emulsified in complete Freund's adjuvant induced a Th1 response, which accelerated the rejection of skin allografts, but it had no effect on cardiac transplants. In contrast, induction of a Th2 response to the same peptide abrogated the CD8+ cytotoxic T cells response and markedly delayed the rejection of skin allografts while it induced de novo chronic rejection of heart transplants. This shows that Th2 cells activated via indirect allorecognition can exert dual effects on acute and chronic rejection of allogeneic transplants.This publication has 63 references indexed in Scilit:
- Role of Alloantibodies in the Pathogenesis of Graft Arteriosclerosis in Cardiac TransplantationAmerican Journal of Transplantation, 2006
- Chronic heart allograft rejection in rats demonstrates a dynamic interplay between IFN-γ and IL-10 producing T cellsTransplant Immunology, 2004
- Predominant expression of the Th2 response in chronic cardiac allograft rejectionTransplant International, 2003
- CHRONIC ALLOGRAFT REJECTIONTransplantation, 1999
- CARDIAC ALLOGRAFT VASCULOPATHYTransplantation, 1997
- Antigen processing and presentation in transplantationCurrent Opinion in Immunology, 1996
- Induction of T H 1 and T H 2 Immunity in Neonatal MiceScience, 1996
- Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.JCI Insight, 1996
- Chronic Allograft RejectionImmunological Reviews, 1993
- Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.The Journal of Experimental Medicine, 1992